Mabion S.A. (MAB.WA)
PLN 9.49
(-4.33%)
PLN 9.49
(-4.33%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 114.58 Million PLN | 73.64% |
| 2022 | 65.98 Million PLN | 83.88% |
| 2021 | 35.88 Million PLN | 465.1% |
| 2020 | -9.82 Million PLN | -2009.23% |
| 2019 | -466 Thousand PLN | 41.53% |
| 2018 | -797 Thousand PLN | 17.92% |
| 2017 | -971 Thousand PLN | -28.1% |
| 2016 | -758 Thousand PLN | 73.91% |
| 2015 | -2.9 Million PLN | 14.34% |
| 2014 | -3.39 Million PLN | -1695550.0% |
| 2013 | -200.00 PLN | 99.98% |
| 2012 | -956.21 Thousand PLN | -111.97% |
| 2011 | 7.98 Million PLN | 195.38% |
| 2010 | 2.7 Million PLN | 45300.64% |
| 2009 | -5983.55 PLN | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 26.38 Million PLN | -0.14% |
| 2024 Q3 | -1.71 Million PLN | -106.95% |
| 2024 Q1 | 26.42 Million PLN | -21.19% |
| 2023 Q3 | 23.15 Million PLN | -15.58% |
| 2023 Q2 | 27.43 Million PLN | -9.93% |
| 2023 FY | 114.58 Million PLN | 73.64% |
| 2023 Q1 | 30.45 Million PLN | 1.73% |
| 2023 Q4 | 33.53 Million PLN | 44.8% |
| 2022 Q3 | 8.56 Million PLN | -19.61% |
| 2022 Q1 | 16.4 Million PLN | -52.78% |
| 2022 FY | 65.98 Million PLN | 83.88% |
| 2022 Q4 | 29.94 Million PLN | 249.45% |
| 2022 Q2 | 10.65 Million PLN | -35.02% |
| 2021 FY | 35.88 Million PLN | 465.1% |
| 2021 Q4 | 34.73 Million PLN | 12160.76% |
| 2021 Q1 | -2.18 Million PLN | -834.68% |
| 2021 Q3 | -288 Thousand PLN | -128.51% |
| 2021 Q2 | 1.01 Million PLN | 146.29% |
| 2020 Q1 | -110 Thousand PLN | -214.58% |
| 2020 Q4 | 297 Thousand PLN | 360.53% |
| 2020 FY | -9.82 Million PLN | -2009.23% |
| 2020 Q3 | -114 Thousand PLN | -56.16% |
| 2020 Q2 | -73 Thousand PLN | 33.64% |
| 2019 Q4 | 96 Thousand PLN | 171.64% |
| 2019 FY | -466 Thousand PLN | 41.53% |
| 2019 Q1 | -188 Thousand PLN | 29.32% |
| 2019 Q2 | -240 Thousand PLN | -27.66% |
| 2019 Q3 | -134 Thousand PLN | 44.17% |
| 2018 Q1 | -202 Thousand PLN | 45.26% |
| 2018 FY | -797 Thousand PLN | 17.92% |
| 2018 Q3 | -242 Thousand PLN | -178.16% |
| 2018 Q2 | -87 Thousand PLN | 56.93% |
| 2018 Q4 | -266 Thousand PLN | -9.92% |
| 2017 Q4 | -369 Thousand PLN | -24.24% |
| 2017 Q3 | -297 Thousand PLN | -133.86% |
| 2017 Q2 | -127 Thousand PLN | 28.65% |
| 2017 Q1 | -178 Thousand PLN | 76.52% |
| 2017 FY | -971 Thousand PLN | -28.1% |
| 2016 Q2 | -257 Thousand PLN | -69.08% |
| 2016 Q1 | -152 Thousand PLN | 90.29% |
| 2016 FY | -758 Thousand PLN | 73.91% |
| 2016 Q4 | -758 Thousand PLN | -376.73% |
| 2016 Q3 | -159 Thousand PLN | 38.13% |
| 2015 Q1 | -926 Thousand PLN | 17.34% |
| 2015 Q2 | 850.44 Thousand PLN | 191.84% |
| 2015 FY | -2.9 Million PLN | 14.34% |
| 2015 Q4 | -1.56 Million PLN | -37.49% |
| 2015 Q3 | -1.13 Million PLN | -233.93% |
| 2014 FY | -3.39 Million PLN | -1695550.0% |
| 2014 Q4 | -1.12 Million PLN | -17.31% |
| 2014 Q3 | -955 Thousand PLN | -23.87% |
| 2014 Q2 | -771 Thousand PLN | -40.18% |
| 2014 Q1 | -550 Thousand PLN | 74.98% |
| 2013 Q1 | -90 Thousand PLN | 94.46% |
| 2013 Q3 | -863 Thousand PLN | 18.28% |
| 2013 Q4 | -2.19 Million PLN | -154.72% |
| 2013 Q2 | -1.05 Million PLN | -1073.33% |
| 2013 FY | -200.00 PLN | 99.98% |
| 2012 Q2 | -372 Thousand PLN | -765.12% |
| 2012 Q4 | -1.62 Million PLN | -1375.65% |
| 2012 FY | -956.21 Thousand PLN | -111.97% |
| 2012 Q1 | -43 Thousand PLN | 0.0% |
| 2012 Q3 | -110 Thousand PLN | 70.43% |
| 2011 FY | 7.98 Million PLN | 195.38% |
| 2010 FY | 2.7 Million PLN | 45300.64% |
| 2009 FY | -5983.55 PLN | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bioceltix S.A. | -1.03 Million PLN | 11138.018% |
| BIOTON S.A. | 72.85 Million PLN | -57.28% |
| Captor Therapeutics Spolka Akcyjna | 6.9 Million PLN | -1560.383% |
| Molecure S.A. | -4.1 Million PLN | 2893.611% |
| NanoGroup S.A. | -79.01 Thousand PLN | 145110.567% |
| Pharmena S.A. | 5.84 Million PLN | -1861.03% |
| Poltreg S.A. | -1.38 Million PLN | 8361.211% |
| Pure Biologics Spólka Akcyjna | -2.57 Million PLN | 4551.554% |
| Ryvu Therapeutics S.A. | 29.3 Million PLN | -290.988% |
| Synthaverse S.A. | 35.16 Million PLN | -225.825% |
| Urteste S.A. | -479 Thousand PLN | 24021.294% |